Advertisement
Screener

XERIS BIOPHARMA HOLDINGS, INC. (XERS) Auditor

XERIS BIOPHARMA HOLDINGS, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-02: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Grand Rapids, Michigan.
  • 2025-03-06: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Grand Rapids, Michigan.
  • 2024-03-06: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Grand Rapids, Michigan.
  • 2023-03-08: Fiscal year end 2022-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location Chicago, Illinois.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-022025-12-31Ernst & Young LLP42Grand Rapids, MichiganYes
2025-03-062024-12-31Ernst & Young LLP42Grand Rapids, MichiganYes
2024-03-062023-12-31Ernst & Young LLP42Grand Rapids, MichiganYes
2023-03-082022-12-31KPMG LLP185Chicago, IllinoisNo
2022-03-112021-12-31KPMG LLP185Chicago, IllinoisNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Innoviva, Inc. (INVA)United States$1.493B4.62
Xencor Inc (XNCR)United States$1.776B-7.33
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Septerna, Inc. (SEPN)United States$1.783B-63.01